Role of Rapid Virologic Response in Determining Treatment Duration of Peginterferon Alfa-2b/Ribavirin in Chronic Hepatitis C Genotype 4.
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2008
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 28 Feb 2008 The expected completion date for this trial is now 1 Apr 2007, as reported by clinicaltrials.gov.
- 25 Feb 2008 Status change from in progress to completed, as reported by clinicaltrials.gov.
- 21 Jul 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History